Roundtable Discussion: Specialty vs. Retail Pharmacies in CNS Therapeutics – Navigating Access, Margins, & Patient Support
Time: 1:00 pm
day: Conference Day One
Details:
- How shrinking margins, generics, and store closures have impacted retail’s role in CNS therapy access, and why it’s becoming less viable for novel treatments
- The growing importance of specialty pharmacies for large-molecule and complex CNS drugs, and their role in delivering enhanced services like prior authorization and assignment of benefits
- Strategic considerations for manufacturers in choosing the right distribution model early, balancing prescriber burden, payer requirements, and patient logistics
